Literature DB >> 7881649

Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease. Clinicopathologic correlative studies.

A Nagai1, W M Thurlbeck, K Konno.   

Abstract

We have studied the relationships between pulmonary lesions and bronchodilator response and variability of FEV1 in 41 patients enrolled in the National Institutes of Health Intermittent Positive Pressure Breathing Trial who died, came to autopsy, and provided adequate tissue to quantitate lesions. The patients had moderate to severe chronic airflow obstruction and various degrees of response to 250 micrograms isoproterenol inhalation. Airway responsiveness was positively correlated with bronchial eosinophilia, bronchial inflammation, and bronchiolar fibrosis, and it was negatively correlated with bronchiolar goblet cell metaplasia and emphysema. Patients with an increase of 190 ml or more in FEV1 after bronchodilator had less bronchial cartilage and less goblet metaplasia in bronchioles. Airway smooth muscle was not related to airway responsiveness and variability. Flow rates were adversely affected by bronchial eosinophilia for given emphysema scores. This study shows the importance of the eosinophil as part of chronic nonspecific lung disease. Lack of airway responsiveness was associated with lesions such as emphysema and goblet cell metaplasia, which by themselves cause severe chronic airflow obstruction. The better-preserved lung function in patients with increased airway responsiveness is attributed to negative correlations with emphysema and positive correlations with bronchial eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7881649     DOI: 10.1164/ajrccm/151.3_Pt_1.635

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  5 in total

1.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

Review 2.  Celebration of the 50-Year Anniversary of the National Heart, Lung, and Blood Institute Division of Lung Diseases: A Half-Century of Landmark Clinical Trials.

Authors:  Robert A Wise; Jerry A Krishnan
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

3.  Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI.

Authors:  Dmitriy A Yablonskiy; Alexander L Sukstanskii; Jason C Leawoods; David S Gierada; G Larry Bretthorst; Stephen S Lefrak; Joel D Cooper; Mark S Conradi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.

Authors:  G T Verhoeven; J P J J Hegmans; P G H Mulder; J M Bogaard; H C Hoogsteden; J-B Prins
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

5.  Noninvasive quantification of alveolar morphometry in elderly never- and ex-smokers.

Authors:  Gregory A Paulin; Alexei Ouriadov; Eric Lessard; Khadija Sheikh; David G McCormack; Grace Parraga
Journal:  Physiol Rep       Date:  2015-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.